5914 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1744)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2527)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)

More Groups

People
  1. Marc Ladanyi (1327)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (120)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (263)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (758)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5914)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I study of oral BKM120 and oral olaparib for high-grade serous ovarian cancer (HGSC) or triple-negative breast cancer (TNBC)
    Meeting Abstract

    Matulonis, U.; Wulf, G. M.; Birrer, M. J.; Westin, S. N.; Quy, P.; Bell-Mcguinn, K. M.; Lasonde, B.; Whalen, C.; Aghajanian, C.; Solit, D. B.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Prevalence of germline BAP1 mutations in patients with malignant mesothelioma (MM)
    Meeting Abstract

    Hellmann, M. D.; Borsu, L.; Zehir, A.; Cheng, D. T.; Zha, Z.; Siegel, B.; Rohrer, R. W.; Robson, M. E.; Arnold, A. G.; Fleischut, M. H.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Alterations in two oncogenic drivers: Impact of concurrent PIK3CA or AKT1 mutations in patients with oncogene-driven lung adenocarcinomas
    Meeting Abstract

    Eng, J.; Hellmann, M. D.; Woo, K.; Sima, C. S.; Yu, H. A.; Arcila, M. E.; Ladanyi, M.; Kris, M. G.; Drilon, A. E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinicopathologic features of advanced RET fusion-positive lung cancers and outcomes in comparison to other fusion-positive lung cancers
    Meeting Abstract

    Drilon, A. E.; Hellmann, M. D.; Wang, L.; Cho, E. J.; Ladanyi, M.; Rizvi, N. A.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in "pan-negative" lung adenocarcinomas (ADC) from patients with no smoking or a light smoking (NS/LS) history
    Meeting Abstract

    Drilon, A. E.; Wang, L.; Arcila, M. E.; Cho, E. J.; Balasubramanian, S.; Greenbowe, J. R.; Ross, J. S.; Stephens, P.; Lipson, D.; Miller, V. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A virtual consult service to optimize clinical trial participation in patients with metastatic breast cancer
    Meeting Abstract

    Cadoo, K. A.; Shah, P. D.; Charen, A. S.; Bromberg, J.; Comen, E. A.; D'Andrea, G.; Dang, C. T.; Gilewski, T.; Gucalp, A.; Lake, D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis
    Journal Article

    Dong, Y.; Van Tine, B. A.; Oyama, T.; Wang, P. I.; Cheng, E. H.; Hsieh, J. J.
    Cell Research (2014)

    Fulltext@MSK | Save
  • Analytical validation of solid tumor fusion gene detection in a comprehensive NGS-based clinical cancer genomic test
    Meeting Abstract

    Yelensky, R.; Donahue, A.; Otto, G.; Nahas, M.; He, J.; Juhn, F.; Downing, S.; Frampton, G. M.; Chmielecki, J.; Ross, J. S.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Oncogenic RAF mutants that signal as functional dimers are resistant to current RAF inhibitors but sensitive to a novel inhibitor of RAF dimer kinase activity
    Meeting Abstract

    Yao, Z.; Torres, M.; Wei, M.; Hanrahan, A.; Abdel-Wahab, O.; Solit, D.; Luo, L. S.; Poulikakos, P.; Rosen, N.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Comprehensive characterization of urothelial bladder cancer: A TCGA Project update
    Meeting Abstract

    Weinstein, J. N.; Kim, J.; Creighton, C. J.; Akbani, R.; Hoadley, K. A.; Kim, W. Y.; Morgan, M. B.; Hinoue, T.; Cherniack, A.; Su, X.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save